Availability of human eye tissues has fueled major advances in understanding the mechanisms of blinding diseases through laboratory research. This is particularly true for eye diseases that occur primarily in humans, such as age-related macular degeneration and open-angle glaucoma. As a recent example, experimentation on human eye tissue laid the foundation for recent development of Rho-kinase inhibitors, a novel class of glaucoma therapeutics that increase aqueous humor outflow facility.1 Unfortunately, during a time of some of the greatest discoveries in vision science, researchers face a shortage of human eye tissue, as the number of eyes donated for research continues to decline.2
Williams AM, Stamer WD, Allingham RR. Increasing the Availability and Quality of Donor Eyes for Research. JAMA Ophthalmol. 2016;134(4):351–352. doi:10.1001/jamaophthalmol.2015.5492
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: